We are live on ! Find out more
KTOVW

Kitov Pharma Ltd. Warrants

Delisted

KTOVW was delisted on the 23rd of November, 2020.

5 hedge funds and large institutions have $167K invested in Kitov Pharma Ltd. Warrants in 2016 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

25% more funds holding

Funds holding: 45 (+1)

84% less capital invested

Capital invested by funds: $1.04M → $167K (-$877K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
5
Holders Change
+1
Holders Change %
+25%
% of All Funds
0.13%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
Reduced
1
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
ICM
1
Ionic Capital Management
New York
$120K -$6.8K -8,364 -7%
RJA
2
Raymond James & Associates
Florida
$16K +$11.8K +14,500 New
VKH
3
Virtu KCG Holdings
New York
$16K +$12K +14,811 New
BA
4
BlackRock Advisors
Delaware
$13K
Wells Fargo
5
Wells Fargo
California
$2K
SM
6
Sabby Management
Florida
-$944K -1,210,785 Closed

KTOVW Hedge Fund Activity: Q3 2016 in Review

5 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Kitov Pharma Ltd. Warrants (KTOVW) for Q3 2016, worth a combined $167K — down 84% from $1.04M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new KTOVW positions and 1 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.

The largest buyer was Virtu KCG Holdings, opening a new position worth an estimated $12K. The largest seller was Sabby Management, exiting entirely with an estimated $944K sold.

  • 5 institutional investors held Kitov Pharma Ltd. Warrants (KTOVW) as of Q3 2016, up from 4 in Q2 2016.
  • Funds reported $167K of Kitov Pharma Ltd. Warrants stock for Q3 2016, down 84% quarter-over-quarter.
  • 2 funds opened new Kitov Pharma Ltd. Warrants positions in Q3 2016 and 1 closed out, a net change of +1 holder.
  • The largest Kitov Pharma Ltd. Warrants buyer in Q3 2016 was Virtu KCG Holdings, an estimated $12K added.
  • The largest Kitov Pharma Ltd. Warrants seller in Q3 2016 was Sabby Management, an estimated $944K sold.

Based on aggregated 13F filings for Q3 2016.